Re: Farmas USA
INSM ... huele a dilucion si o si este año ...
As of June 30, 2017, Insmed had cash and cash equivalents of approximately $91 million. The Company's operating expenses for the second quarter of 2017 were approximately $44 million, and its cash-based operating expenses (as defined below) for the second quarter of 2017 were approximately $38 million. Insmed ended the second quarter of 2017 with approximately $55 million in debt.